急性冠動脈症候群におけるマーカー: 経皮冠動脈介入における遠隔冠動脈栓塞
Niya Emilova Semerdzhieva1, Simeon Dimitrov2, Adelina Tsakova3
1Clinic of Internal Medicine, University Emergency Hospital 'Pirogov', 1606 Sofia, Bulgaria.
Journal of cardiovascular development and disease
|August 27, 2025
まとめ
急性冠動脈症候群 (ACS) の経皮冠動脈干渉 (PCI) 中の遠隔冠動脈栓塞は,血流の鈍化に関連しています. 高濃度のデヒドロエピアンドロステロン硫酸 (DHEA- S) はリスクを示し,高濃度のトリグリセリドはPCI後の緩やかな流れと関連しています.
科学分野:
- 心血管医学
- 介入心臓科
- 生物化学
背景:
- 角動脈栓塞は,急性心筋梗塞 (AMI) の患者の最大30. 5%で皮膚経冠動脈介入 (PCI) を合併させる.
- これらの栓塞は,心臓発作に関連する動脈領域における心筋再注血の障害と関連しています.
- 急性冠動脈症候群 (ACS) のPCI結果を改善するために,遠隔冠動脈栓塞の指標を特定することが重要です.
研究 の 目的:
- PCI で血管図で検出された遠隔冠動脈栓塞の検査,臨床,イメージング指標を特定する.
- ステントを挿入したACS患者における様々なバイオマーカーと遠隔冠動脈栓塞の発生率の関係を分析する.
主な方法:
- ステントを挿入したPCIを受けた137人のACS患者の分析
- 心臓酵素,炎症マーカー,性ステロイド (デヒドロエピアンドロステロン硫酸 [DHEA-S]を含む),血清脂質,酸化低密度脂質 (oxLDL) の測定
- 測定されたバイオマーカーの相関関係と遠隔冠動脈栓塞および慢動脈の発生率
主要な成果:
- 慢動脈の血流は9. 4%の患者で観察された.
- トリグリセリド (TG),高密度リポプロテイン (HDL),グルコース,DHEA- Sのレベルは,遠隔冠動脈栓塞と遅い流れとの関連を示した.
- 多変量分析では,PCI後のDHEA- Sのみが,遠隔冠動脈栓塞のリスクを示す傾向を示した (p=0. 071).
結論:
- ACS患者におけるトリグリセリド濃度の上昇は,ステントを挿入したPCI後に血流が遅くなるリスクを高めます.
- DHEA- S濃度の上昇は,ACSと冠動脈干渉に関連したシンパトアドレナおよび下垂体- 腎上腺の過活性を反映する可能性があります.
- ディスタル冠動脈栓塞の予測におけるDHEA-Sおよび他のバイオマーカーの役割を明らかにするために,さらなる研究が必要である.
関連する概念動画
01:30Acute Coronary Syndrome I: Introduction
71
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
45
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
45
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:28Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
01:29Pulmonary Embolism I: Introduction
45
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332